Literature DB >> 21901643

Independent risk factors for cardiac operations in adults with congenital heart disease: a retrospective study of 543 operations for 500 patients.

Manfred Otto Vogt1, Jürgen Hörer, Sophie Grünewald, Daniela Otto, Harald Kaemmerer, Christian Schreiber, John Hess.   

Abstract

Adults with congenital heart disease (CHD) are an increasing population requiring cardiac operations. To date, the perioperative risk factors for this group have not been identified. This study aimed to identify clinical, morphologic, and hemodynamic risk factors for an adverse outcome. This study retrospectively analyzed a cohort of 500 patients (ages >16 years) who underwent 543 operations between January 2004 and December 2008 at a single center. The composite end point of an adverse outcome was in-hospital death, a prolonged intensive care exceeding 4 days, or both. The composite end point was reached by 253 of the patients (50.6%). Of the 500 patients, 13 (2.6%) died within 30 days after the operation. After logistic regression analysis, the following eight items remained significant: male gender (P = 0.003; odds ratio [OR] 1.8; 95% confidence interval [CI] 1.2-2.6), cyanosis (P > 0.006; OR 3.7; 95% CI 1.5-9.4), functional class exceeding 2 (P = 0.004; OR 2.2; 95% CI 1.3-3.7), chromosomal abnormalities (P = 0.004; OR 3.3; 95% CI 1.4-7.7), impaired renal function (P = 0.019; OR 3.8; 95% CI 1.2-11.5), systemic right ventricle (RV) in a biventricular circulation (P = 0.027; OR 3.3; 95% CI 1.1-9.5), enlargement of the systemic ventricle (P = 0.011; OR 1.7; 95% CI 1.1-2.6), and operation with extracorporeal circulation (P = 0.002; OR 4.3; 95% CI 1.7-11.4). Early mortality in the current adult CHD population is low. Morbidity, however, is significant and influenced by the patients' conditions (male gender, chromosomal abnormalities), history (cyanosis, New York Hospital Association [NYHA] class), and underlying morphology (systemic RV). This information for a large cohort of patients could help progress toward more adequate counseling for adults with a congenital heart defect.

Entities:  

Mesh:

Year:  2011        PMID: 21901643     DOI: 10.1007/s00246-011-0093-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  26 in total

Review 1.  CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I.

Authors:  J Therrien; A Dore; W Gersony; L Iserin; R Liberthson; F Meijboom; J M Colman; E Oechslin; D Taylor; J Perloff; J Somerville; G D Webb
Journal:  Can J Cardiol       Date:  2001-09       Impact factor: 5.223

2.  Improvement in long-term survival after hospital discharge but not in freedom from reoperation after the change from atrial to arterial switch for transposition of the great arteries.

Authors:  Jürgen Hörer; Christian Schreiber; Julie Cleuziou; Manfred Vogt; Zsolt Prodan; Raymonde Busch; Klaus Holper; Rüdiger Lange
Journal:  J Thorac Cardiovasc Surg       Date:  2009-02       Impact factor: 5.209

3.  Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects.

Authors:  Guido Michielon; Bruno Marino; Gianluca Oricchio; Maria Cristina Digilio; Fiore Iorio; Sergio Filippelli; Silvia Placidi; Roberto M Di Donato
Journal:  J Thorac Cardiovasc Surg       Date:  2009-05-23       Impact factor: 5.209

4.  The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease.

Authors:  Peter Engelfriet; Eric Boersma; Erwin Oechslin; Jan Tijssen; Michael A Gatzoulis; Ulf Thilén; Harald Kaemmerer; Philip Moons; Folkert Meijboom; Jana Popelová; Valérie Laforest; Rafael Hirsch; Luciano Daliento; Erik Thaulow; Barbara Mulder
Journal:  Eur Heart J       Date:  2005-07-04       Impact factor: 29.983

5.  Adult congenital heart disease: intensive care management and outcome prediction.

Authors:  Susanna Price; Sian Isobel Jaggar; Simon Jordan; Sarah Trenfield; Mohammed Khan; Babulal Sethia; Darryl Shore; Timothy W Evans
Journal:  Intensive Care Med       Date:  2007-02-27       Impact factor: 17.440

6.  Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations.

Authors:  Alessandro Giamberti; Massimo Chessa; Raul Abella; Gianfranco Butera; Concetta Carlucci; Halkawt Nuri; Alessandro Frigiola; Marco Ranucci
Journal:  Ann Thorac Surg       Date:  2009-10       Impact factor: 4.330

7.  Midterm results of surgical intervention for congenital heart disease in adults: an Italian multicenter study.

Authors:  Massimo A Padalino; Simone Speggiorin; Giulio Rizzoli; Giancarlo Crupi; Vladimiro L Vida; Massimo Bernabei; Gaetano Gargiulo; Alessandro Giamberti; Francesco Santoro; Carlo Vosa; Giuseppe Pacileo; Raffaele Calabrò; Luciano Daliento; Giovanni Stellin
Journal:  J Thorac Cardiovasc Surg       Date:  2007-07       Impact factor: 5.209

8.  Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.

Authors:  Konstantinos Dimopoulos; Gerhard-Paul Diller; Evdokia Koltsida; Antonia Pijuan-Domenech; Sofia A Papadopoulou; Sonya V Babu-Narayan; Tushar V Salukhe; Massimo F Piepoli; Philip A Poole-Wilson; Nicky Best; Darrel P Francis; Michael A Gatzoulis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

9.  How well are patients doing up to 30 years after a mustard operation?

Authors:  J Hörer; F Herrmann; C Schreiber; J Cleuziou; Z Prodan; M Vogt; K Holper; R Lange
Journal:  Thorac Cardiovasc Surg       Date:  2007-09       Impact factor: 1.827

10.  Predictors of mortality in adult patients with congenital heart disease.

Authors:  Olga Trojnarska; Stefan Grajek; Sławomir Katarzyński; Lucyna Kramer
Journal:  Cardiol J       Date:  2009       Impact factor: 2.737

View more
  1 in total

1.  First-in-Human Closed-Chest Transcatheter Superior Cavopulmonary Anastomosis.

Authors:  Kanishka Ratnayaka; John W Moore; Rodrigo Rios; Robert J Lederman; Sanjeet R Hegde; Howaida G El-Said
Journal:  J Am Coll Cardiol       Date:  2017-08-08       Impact factor: 24.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.